Valuation: Treace Medical Concepts, Inc.

Market Cap 282M 242M 226M 207M 388M 27.01B 394M 2.67B 1.04B 13.56B 1.06B 1.04B 44.86B P/E 2026 *
-5.1x
P/E 2027 * -5.6x
Enterprise Value 328M 281M 263M 240M 451M 31.38B 457M 3.1B 1.21B 15.75B 1.23B 1.2B 52.12B EV / Sales 2026 *
1.58x
EV / Sales 2027 * 1.66x
Free-Float
74.51%
Yield 2026 *
-
Yield 2027 * -
1 day-2.69%
1 week-9.39%
Current month+0.70%
1 month+2.60%
3 months+52.82%
6 months+129.63%
Current year+77.14%
1 week 4.28
Extreme 4.275
4.75
1 month 3.85
Extreme 3.85
5.2
Current year 1.17
Extreme 1.17
5.2
1 year 1.17
Extreme 1.17
7.78
3 years 1.17
Extreme 1.17
16.28
5 years 1.17
Extreme 1.17
31.02
10 years 1.17
Extreme 1.17
37.17
Manager TitleAgeSince
Chief Executive Officer 54 2013-06-30
Director of Finance/CFO 56 2020-08-31
Chief Tech/Sci/R&D Officer - 2022-02-28
Director TitleAgeSince
Chairman 54 2025-05-19
Director/Board Member 65 2020-11-19
Director/Board Member 68 2020-11-19
Date Insider Type Main position Quantity % Market Cap.
8/9/26 Tax

Chief Financial Officer

-37,102 0.0572%
8/9/26 Tax

Responsable ventes & marketing

-9,814 0.0151%
8/9/26 Tax

Compliance Officer

-16,253 0.0251%
Change 5-day change 1-year change 3-year change Capi.($)
-2.69%-9.39%-40.22%-71.45% 282M
+0.44%-0.56%+29.36%+30.75% 12.81B
-0.73%+1.75%+19.17%+33.90% 7.03B
-1.96%+4.36%+53.35%+47.77% 6.75B
+1.34%+1.49% - - 5.74B
-1.02%+20.98%-7.22%+79.99% 5.46B
-3.05%-3.63%-30.58%-24.96% 3.78B
-3.77%+0.88%+43.58%-45.10% 1.99B
+4.24%+8.45%-24.36%+131.08% 1.69B
-2.10%-7.62%+44.08%-11.01% 1.58B
Average -0.93%+1.90%+9.68%+19.00% 4.71B
Weighted average by Cap. -0.56%+3.31%+19.82%+33.62%

Financials

2026 *2027 *
Net sales 207M 178M 166M 152M 286M 19.86B 289M 1.96B 765M 9.96B 779M 762M 32.98B 222M 190M 178M 163M 305M 21.22B 309M 2.1B 818M 10.65B 832M 814M 35.24B
Net income -55.26M -47.32M -44.26M -40.52M -76.07M -5.29B -77.09M -523M -204M -2.65B -207M -203M -8.78B -51.01M -43.68M -40.85M -37.4M -70.21M -4.88B -71.16M -483M -188M -2.45B -192M -187M -8.11B
Net Debt 45.67M 39.11M 36.57M 33.48M 62.86M 4.37B 63.7M 432M 168M 2.19B 171M 168M 7.26B 86.44M 74.02M 69.22M 63.37M 119M 8.27B 121M 818M 319M 4.15B 325M 317M 13.74B
Logo Treace Medical Concepts, Inc.
Treace Medical Concepts, Inc. is a medical technology company. It is advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities, the SpeedMTP Rapid Compression Implant for addressing bunions through big toe joint fusions, and two systems for minimally invasive osteotomy surgeries: the Nanoplasty 3D Minimally Invasive Bunion Correction System and the Percuplasty Percutaneous 3D Bunion Correction System. It sells its products to physicians, surgeons, ambulatory surgery centers, hospitals, and stocking distributors.
Employees
450
Date Price Change Volume
26-08-21 US$4.340 -2.69% 277,510
26-08-20 US$4.460 -2.19% 271,101
26-08-19 US$4.560 +2.47% 398,356
26-08-18 US$4.450 -1.11% 227,164
26-08-17 US$4.500 -6.05% 193,260
Trader
Investor
-
Global
-
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
4.340USD
Average target price
5.500USD
Spread / Average Target
+26.73%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. TMCI Stock